Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
NCT ID: NCT02232893
Description: None
Frequency Threshold: 5
Time Frame: 2 months
Study: NCT02232893
Study Brief: Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Daikenchuto (TU-100) Daikenchuto (TU-100) 5g TID (15g/day) Daikenchuto (TU-100): Subjects will receive 5g TID (15g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 3 days before surgery and 28 days after surgery. 0 None 3 34 29 34 View
Placebo Placebo TID Placebo: Subjects will receive daily dose of TU-100 placebo. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 3 days before surgery and 28 days after surgery. 0 None 4 32 23 32 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Post-operative Ileus SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Post-operative Wound Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Hypertensive emergency SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.1) View
Small bowel obstruction SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Mental Status Changes SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Muscle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Procedural pain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Incision site pain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Procedural nausea SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Pruritis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.1) View
Oropharyngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.1) View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.1) View
Bladder Spasm SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (17.1) View
Tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (17.1) View